Echometrix, a Madison medical technology company, has received U.S. Food and Drug Administration approval to sell its EchoSoft ultrasound technology.”We?re very pleased to have reached this critical milestone,” said chief executive Sam Adams. The application was submitted in spring 2011. Founded in 2007 based on UW-Madison research, Echometrix has three employees. Adams said he plans to hire at least one more by the end of the year.
Office of Strategic Communication